Home » Stocks » EKIMAS Corporation

EKIMAS Corporation (ASNB)

Stock Price: $0.0200 USD -0.0026 (-11.50%)
Updated Aug 6, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 565,248
Revenue (ttm) 3.35M
Net Income (ttm) 210,000
Shares Out 28.26M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $0.0200
Previous Close $0.0226
Change ($) -0.0026
Change (%) -11.50%
Day's Open 0.0230
Day's Range 0.0230 - 0.0230
Day's Volume 7,598
52-Week Range 0.0200 - 0.2300

More Stats

Market Cap 565,248
Enterprise Value 118,248
Earnings Date (est) n/a
Ex-Dividend Date Apr 24, 2020
Shares Outstanding 28.26M
Float 22.14M
EPS (basic) 0.01
EPS (diluted) -0.01
FCF / Share 0.01
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 53.78%
Payout Ratio n/a
Shares Short 19,919
Short Ratio 0.98
Short % of Float 0.09%
Beta -1.94
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 1.86
PS Ratio 0.17
PB Ratio n/a
Revenue 3.35M
Operating Income 730,000
Net Income 210,000
Free Cash Flow 304,000
Net Cash 447,000
Net Cash / Share 0.02
Gross Margin 73.79%
Operating Margin 21.82%
Profit Margin 7.80%
FCF Margin 9.09%
ROA 14.59%
ROE n/a
ROIC 38.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$2.00*
Low
2.00
Current: $0.0200
High
2.00
Target: 2.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2018201720162015201420132012201120102009
Revenue3.352.922.283.182.572.632.201.871.672.12
Revenue Growth14.67%27.76%-28.2%23.58%-1.98%19.64%17.63%12%-21.3%-
Gross Profit2.472.121.432.101.651.621.380.970.140.76
Operating Income0.750.18-0.140.400.07-0.21-0.67-1.50-3.19-2.62
Net Income0.33-0.20-0.510.03-0.32-0.52-1.01-1.81-3.19-1.69
Shares Outstanding21.4921.4921.4921.4921.4921.4921.4921.4221.3121.15
Earnings Per Share0.01-0.01-0.02--0.01-0.02-0.05-0.08-0.15-0.08
Operating Cash Flow0.080.11-0.200.06-0.190.17-0.48-1.75-2.59-1.61
Capital Expenditures-0.02-0.01---0.05----0.02
Free Cash Flow0.060.10-0.200.06-0.190.21-0.48-1.75-2.59-1.64
Cash & Equivalents0.170.120.030.080.080.270.100.480.483.06
Total Debt0.142.132.141.992.042.041.991.99--
Net Cash / Debt0.03-2.01-2.11-1.91-1.97-1.77-1.88-1.500.483.06
Assets2.982.922.432.582.802.893.123.953.806.87
Liabilities3.513.423.032.672.972.752.502.350.440.46
Book Value-0.53-0.50-0.60-0.10-0.170.140.621.603.366.42
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name EKIMAS Corporation
Country United States
Employees 11
CEO Michael F. Adams

Stock Information

Ticker Symbol ASNB
Stock Exchange US OTC
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier OTCMKTS: ASNB
IPO Date June 12, 1996

Description

EKIMAS Corporation develops polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It offers polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names. The company also manufactures specialty hydrophilic polyurethanes. It sells its products in the United States and internationally. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was founded in 1993 and is headquartered in Wilmington, Massachusetts.